The effect of high intensity interval training (HIIT) on serum levels of selenoprotein P and glycemic and body composition indices in women with nonalcoholic fatty liver disease

Document Type : Research Paper I Open Access I Released under (CC BY-NC 4.0) license

Authors

1 Associate Professor of Sports Physiology, Department of Sports Sciences, Faculty of Educational Sciences and Psychology, Azerbaijan Shahid Madani University, Tabriz-Iran.

2 M.Sc, Department of Exercise Sciences, Faculty of Education and Psychology, Azarbaijan Shahid Madani University, Tabriz, Iran.

Abstract

Aim:   Inactivity and incorrect eating habits are the most important factors in the prevalence of non-alcoholic fatty liver disease. Therefore, due to the importance of preventing metabolic diseases, the aim of this study was to evaluate the effect of high intensity interval training (HIIT) on serum levels of selenoprotein P, glycemic and body composition indices in women with non-alcoholic fatty liver disease. Methods:  The present study was a quasi-experimental study in which women with non-alcoholic fatty liver disease, 25 of whom were randomly divided into two exercise (13) and control (12) group. The HIIT protocol was performed for 8 weeks and four sessions per week for 60 minutes each session. Blood samples were taken in pre and post-test to measure serum levels of selenoprotein P and other variables. Statistical analysis of data was performed by using paired and independent t-test by spss21 software at significant level of p <0.05. Results:   The results was showed that after eight weeks of HIIT in the training group compared to the control group, the amounts of selenoprotein , insulin resistance index, body fat percentage, BMI, WHR and body weight  decreased significantly. Conclusions:   It seems that HIITcan be suggested as a suitable strategy to improve the levels of selenoprotein P, insulin resistance and body composition indices in non-alcoholic fatty liver disease.
 

Keywords

Main Subjects

   

 

This is an open access article distributed under the following Creative Commons license: Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)

References

1.             Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84.
2.             Ekelund U, Steene-Johannessen J, Brown WJ, Fagerland MW, Owen N, Powell KE, et al. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. The Lancet. 2016;388(10051):1302-10.
3.             Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. The Lancet Oncology. 2017;18(8):e457-e71.
4.             Birkenfeld AL, Shulman GI. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology. 2014;59(2):713-23.
5.             Nascimbeni F, Romagnoli D, Ballestri S, Baldelli E, Lugari S, Sirotti V, et al. Do nonalcoholic fatty liver disease and fetuin-A play different roles in symptomatic coronary artery disease and peripheral arterial disease? Diseases. 2018;6(1):17.
6.             Huang Z, Rose AH, Hoffmann PR. The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxidants & redox signaling. 2012;16(7):705-43.
7.             Nichol C, Herdman J, Sattar N, O’Dwyer PJ, O’Reilly DSJ, Littlejohn D, et al. Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response? Clinical chemistry. 1998;44(8):1764-6.
8.             Mattmiller S, Carlson BA, Sordillo L. Regulation of inflammation by selenium and selenoproteins: impact on eicosanoid biosynthesis. Journal of nutritional science. 2013;2.
9.             Rayman MP. Selenium and human health. The Lancet. 2012;379(9822):1256-68.
10.           Misu H, Takayama H, Saito Y, Mita Y, Kikuchi A, Ishii K-a, et al. Deficiency of the hepatokine selenoprotein P increases responsiveness to exercise in mice through upregulation of reactive oxygen species and AMP-activated protein kinase in muscle. Nature medicine. 2017;23(4):508-16.
11.           Sargeant JA, Aithal GP, Takamura T, Misu H, Takayama H, Douglas JA, et al. The influence of adiposity and acute exercise on circulating hepatokines in normal-weight and overweight/obese men. Applied Physiology, Nutrition, and Metabolism. 2018;43(5):482-90.
12.           Oh S, So R, Shida T, Matsuo T, Kim B, Akiyama K, et al. High-intensity aerobic exercise improves both hepatic fat content and stiffness in sedentary obese men with nonalcoholic fatty liver disease. Scientific reports. 2017;7(1):1-12.
13.           Cuthbertson DJ, Shojaee-Moradie F, Sprung VS, Jones H, Pugh CJ, Richardson P, et al. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. Clinical science. 2016;130(2):93-104.
14.           Balducci S, Zanuso S, Cardelli P, Salvi L, Bazuro A, Pugliese L, et al. Effect of high-versus low-intensity supervised aerobic and resistance training on modifiable cardiovascular risk factors in type 2 diabetes; the Italian Diabetes and Exercise Study (IDES). PloS one. 2012;7(11):e49297.
15.           Paluch AE, Church TS, Blair SN. Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus. Current Cardiovascular Risk Reports. 2011;5(6):481.
16.           Bacchi E, Negri C, Targher G, Faccioli N, Lanza M, Zoppini G, et al. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). Hepatology. 2013;58(4):1287-95.
17.           Stewart KJ, Bonekamp S, Barone BB, Bacher AC, Potrekus K, Moxley J, et al. Exercise Training Reduces Hepatic Fat in Type 2 Diabetes: A Randomized, Controlled Trial. Journal of Cardiopulmonary Rehabilitation and Prevention. 2008;28(4):269.
18.           Francois ME, Little JP. Effectiveness and safety of high-intensity interval training in patients with type 2 diabetes. Diabetes Spectrum. 2015;28(1):39-44.
19.           Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr 1978;40(3):497-504 .
20.           Burk RF, Hill KE. Selenoprotein P—expression, functions, and roles in mammals. Biochimica et Biophysica Acta (BBA)-General Subjects. 2009;1790(11):1441-7.
21.           Burk RF, Hill KE. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr. 2005;25:215-35.
22.           Ennequin G, Sirvent P, Whitham M. Role of exercise-induced hepatokines in metabolic disorders. American Journal of Physiology-Endocrinology and Metabolism. 2019;317(1):E11-E24.
23.           Stranges S, Laclaustra M, Ji C, Cappuccio FP, Navas-Acien A, Ordovas JM, et al. Higher selenium status is associated with adverse blood lipid profile in British adults. The Journal of nutrition. 2010;140(1):81-7.
24.           Ghorbanian B, Shokrollahi F. The effects of rope training on Paraoxonase-1 enzyme, insulin resistance and lipid profiles in inactive girls. 2017.
25.           Attarzadeh Hosseini SR, Mir E, Hejazi K, Mir Sayeedi M. The effect of eight weeks combined training on some insulin resistance markers in middle-aged men. medical journal of mashhad university of medical sciences. 2015;58(3):129-36.
26.           Henriksen EJ. Invited review: Effects of acute exercise and exercise training on insulin resistance. Journal of applied physiology. 2002;93(2):788-96.
27.           Poirier P, Tremblay A, Broderick TL, Catellier C, Tancrède G, Nadeau A. Impact of moderate aerobic exercise training on insulin sensitivity in type 2 diabetic men treated with oral hypoglycemic agents: is insulin sensitivity enhanced only in nonobese subjects? Medical Science Monitor. 2002;8(2):CR59-CR65.
28.           Irandoost K, RahmaniNia F, Mohebbi H, Mirzaee B, HasanNia S. Effect of aerobic training on ghrelin and leptin plasma in normal and obese women. J Olympic. 2010;50:87-99.
29.           Green JS, Stanforth PR, Rankinen T, Leon AS, Rao D, Skinner JS, et al. The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: the HERITAGE family study. Metabolism. 2004;53(9):1192-6.
30.           Donnelly JE, Hill JO, Jacobsen DJ, Potteiger J, Sullivan DK, Johnson SL, et al. Effects of a 16-month randomized controlled exercise trial on body weight and composition in young, overweight men and women: the Midwest Exercise Trial. Archives of internal medicine. 2003;163(11):1343-50.
31.           Farrel P, Joyner M, Caiozzo V, Medicine ACoS. ACSM’s Advanced Exercise Physiology. Seg. Ed. Baltimore: Lippincott Williams & Wilkins; 2012.
Journal of Applied Health Studies in Sport Physiology
Volume 9, Issue 1
April 2022
Pages 12-21

Files

History

  • Receive Date: 23 June 2021
  • Revise Date: 21 July 2021
  • Accept Date: 31 July 2021

Share

How to cite

Statistics